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The nuclear lamina is a meshwork of intermediate filaments that
lines the nucleoplasmic face of the nuclear membrane and inter-
connects nuclear pores (reviewed by Hozak et al, 1995; Vaughan
et al, 2000). Lamins, or type V intermediate filaments, consist of
two subfamilies termed A-type and B-type. Whilst A and C lamins
(the A-type subfamily) are alternative splice products of a single
gene, there are at least four B-type genes in vertebrates (lamins B1,
B2, B3 and IV (Benavente et al, 1985a; Quinlan et al, 1995).
Lamins have been ascribed a number of diverse functions
including roles in the targeting of nuclear membrane vesicles 
to chromatin after mitosis (Burke and Gerace, 1986), correct
assembly of nuclear pores (Goldberg et al, 1995) and indirectly in
the organization of replication domains (Jenkins et al, 1993; Zhang
et al, 1996). 
A-type and B-type lamins differ in several respects including
their behaviour at mitosis (Gerace and Blobel, 1980), their post-
translational processing (Farnsworth et al, 1989) and their ex-
pression during differentiation. B-type lamins are ubiquitous
components of all cells, although different cells do express
different B-type lamins (Stick and Hausen, 1985; Furukawa 
and Hotta, 1993). The two most prominent B-type lamins in
mammalian somatic cells are lamins B1 and B2, although not all
somatic tissues express both of these B-type lamins (Benavente
and Krohne, 1985b; Stick and Hausen, 1985; Lehner et al, 1987;
Broers et al, 1997). 
The expression of A-type lamins appears to be linked to differ-
entiation and is first observed in embryos at the time of organo-
genesis (Schatten et al, 1985; Stewart and Burke, 1987; Röber
et al, 1989). Pluripotent cells can be induced to express A-type
lamins in culture by treatment that induces differentiation (Lebel
et al, 1987) and in some instances the ectopic expression of lamin
A can promote differentiation (Lourim and Lin, 1992). The cor-
relation between A-type lamin expression and cell differentiation
has led some workers to speculate that A-type lamins may facilit-
ate differential gene expression, by anchoring chromatin at the
nuclear envelope or by sequestering inhibitors (Nigg, 1989).
Consistent with this hypothesis, lamin A displays a higher affinity
for chromatin binding than B-type lamins (Höger et al, 1991). A-
type lamins also bind the negative growth regulator p110RB (Ozaki
et al, 1994). 
The expression of A-type lamins is also altered in many
tumours. In lung tumours there is an inverse correlation between
the level of the proliferation marker Ki67 staining with that of 
the anti-lamin A/C monoclonal BU31 (Rowlands et al, 1994).
Changes in the expression of lamin A has also been reported in
testicular germ cell tumours (Machiels et al, 1997) and Hodgkins
disease (Jansen et al, 1997). In addition, adrenal cortex carcinoma
cell lines and certain lung adenocarcinoma cell lines display
marked imbalances between the expression of lamins A and C
(Paulin-Levasseur et al, 1988; Machiels et al, 1995). The fast
growing small cell lung carcinomas also do not express A-type
lamins whereas non-small cell lung carcinomas do (Broers and
Ramaekers, 1994) reinforcing the suggestion of a relationship
between expression of A type lamins and growth rate and differen-
tiation status. 
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Summary In this study we used a unique collection of type specific anti-lamin antibodies to study lamin expression patterns in normal human
skin and in skin derived from patients with basal cell carcinomas (BCCs). Lamin expression in serial sections from frozen tissue samples was
investigated by single and double indirect immunofluorescence. In normal skin, lamin A was expressed in dermal fibroblasts and in
suprabasal epithelial cells but was absent from all basal epithelial cells. Lamin C was expressed in dermal fibroblasts, suprabasal epithelial
cells and a majority of basal epithelial cells. However, lamin C was not expressed in quiescent basal epithelial cells. Lamin B1 was expressed
in all epithelial cells but was not expressed in dermal fibroblasts. Finally, lamin B2 was expressed in all epithelial cells but was not expressed
in dermal fibroblasts. Finally, lamin B2 was expressed in all cell types in normal skin. Lamin expression was also investigated in a collection of
16 BCCs taken from a variety of body sites. Based upon patterns of lamin expression the BCCs were classified into four groups: A-negative
(10/16 tumours), C-negative (5/16 tumours), A/C-negative (1/16 tumours) and A/B2-negative (1/16 tumours). Lamin expression was also
compared to cell proliferation index by staining serial sections with the proliferation marker Ki67. 9/10 of the lamin A negative tumours were
highly proliferative, whereas 4/5 of the lamin C negative tumours were slow growing. Thus as a general rule absence of lamin A was
correlated with rapid growth within the tumour, while absence of lamin C was correlated with slow growth within the tumour. Our data supports
the hypothesis that lamin A has a negative influence on cell proliferation and its down regulation may be a requisite of tumour progression. 
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In this study we have used an extensive and unique panel of
type-specific lamin antibodies to study lamin expression in human
skin to look further at lamin expression in normal and diseased
tissue. Our results reveal different expression patterns, not only
between A-type and B-type lamins, but also between lamins A and
C and between lamins B1 and B2 in different cell types. Further-
more, we report that while absence of lamin A is characteristic of
basal cell skin carcinomas (BCCs), absence of lamin C occurs in
only a sub-set of BCCs. 
MATERIALS AND METHODS 
Antibodies 
A newly-generated antibody specific for lamin C was used in 
this study. This rabbit antiserum was raised against the last 8
amino acids of lamin C, including an N-terminal lysine as a linker
(KHHVSGSRR). The peptide was coupled to keyhole limpet
haemocyanin through primary amino groups using glutaraldehyde.
The resulting protein-peptide conjugate was dialysed overnight at
4˚C against PBS. The conjugate was then used to immunize a
rabbit. Immune serum was screened by indirect immunofluoresc-
ence and then affinity purified against 10 mg of the lamin C
peptide conjugated to CH Sepharose 4B as described in Harlow
and Lane (1988). 
All the primary antibodies to lamins used in this study are listed
in Table 1, together with their sources and specificities. Rabbit
antiserum to Ki67 was purchased from DAKO and used at a
dilution of 1:50. All secondary antibodies were obtained commer-
cially: FITC- and peroxidase-conjugated goat anti-mouse IgG,
TRITC- and peroxidase-conjugated donkey anti-goat IgG and
FITC-, TRITC- and peroxidase-conjugated sheep anti-rabbit IgG
were all purchased from DAKO and used according to the manu-
facturer’s instructions. All dilutions were done in phosphate
buffered saline (PBS) containing 1% newborn calf serum. 
Immunofluorescence 
HeLa epithelial cells or human dermal fibroblasts (HDF) were
seeded at an initial density of 2 ´ 105 on 90 mm plates containing
13 mm diameter glass coverslips. The cells were grown to approx-
imately 80% confluence in DMEM supplemented with 2 mM glut-
amine, 10 U ml–1 penicillin, 100 mgm l –1 streptomycin, plus 10%
newborn (for HeLa cells) or fetal (for HDF cells) bovine serum.
The cells were then fixed in methanol/acetone (1:1 v/v) for 10
minutes at 4˚C and washed 3 times in PBS before immunostaining. 
Biopsies of normal skin from different body sites (surgical trim-
mings from groin, dorsal-proximal finger, face and back areas) and
of basal cell carcinomas (BCCs) from 16 individual patients were
snap-frozen in liquid nitrogen. Frozen blocks were sectioned on a
Reichert Jung cryomicrotome to give serial sections of approx-
imately 6–7 mm thickness. Sections were collected on uncoated
microscope slides and stored at –70˚C. Prior to use they were
removed from the freezer, thawed and dried rapidly in a stream of
warm air. All staining procedures were then carried out at room
temperature. The sections were incubated with 1% fetal calf serum
in phosphate buffered saline (PBS) for 10 minutes to block non-
specific protein binding, then rinsed in PBS for 5 minutes. 
For immunofluorescence of cells or tissue sections, antibody
incubations were all for 1 h at room temperature in a humidified
environment, followed by 5 min wash in PBS. After the secondary
antibody and wash, a final wash in water was used before mount-
ing. Specimens were mounted in Mowiol containing 1 mg ml–1
DAPI (4´,6-diamidin-2-phenylindol-dihydrochloride) and 1 mg ml–1
DABCO (1,4-diazabicyclo[2.2.2]octane). Immunofluorescence
samples were examined with a Zeiss Axiovert 10 microscope
equipped for epifluorescence using ´ 63 N/A 1.4 and ´ 40 N/A 1.3
PlanNeofluar lenses. Images were collected with a 12 bit CCD
camera using IPLab software. 
Immunoblotting for antibody characterization 
Three fragments of the lamin C gene encoding residues 1–171aa,
171–319aa and 319–572aa were cloned into pGEX expression
vectors and expressed in E. coli strain BL21 and purified accord-
ing to previously published protocols (Dyer et al, 1997; Pugh 
et al, 1997). Nuclear matrix preparations of HeLa cells were
performed following previously published protocols of Mattern 
et al (1992) 
Samples prepared for SDS-PAGE were resolved on a 12% poly-
acrylamide gel. Immunoblotting was carried out as described by
Jenkins et al (1993) using the following primary antibodies (see
Table 1): rabbit anti-lamin C (to lamin C) at 1:1000, JoL2 (to
lamins A,C) used undiluted, JoL4 (to lamin A) used undiluted,
LN43 (to lamin B2) diluted to 1:1000 and affinity purified goat
anti-lamin B1 used at 1:500 (Santa Cruz). Detection of the primary
antibody used antibodies conjugated to horseradish peroxidase as
above. All antibody incubations were for 1 hour at room tempera-
ture. The blots were developed using the ECL detection method. 
RESULTS 
Confirmation of antibody specificities 
The aim of this study was to distinguish between the expression
and distribution of lamin subtypes and an essential first step was
therefore to confirm the antibody specificities. On immuno-
blotting, the rabbit antiserum reacted strongly with fragments
corresponding to peptide 319–572aa of lamin C but with no other
fragment (Figure 1A). When tested against nuclear protein
extracts from HeLa cells monoclonal antibodies specific for lamin
A (JoL4 – Figure 1B, also 133A2) reacted with a single band
migrating at 70 kDa. JoL2 against lamins A and C, reacted with
two bands migrating at 70 kDa and 65 kDa respectively (Figure
1B, lane 1). The anti-peptide antiserum to lamin C reacted with a
single band migrating at 65 kDa (Figure 1B, lane 3). The goat
polyclonal antibody against lamin B1 reacted with a single band
migrating at 67 kDa (Figure 1B, lane 4). Finally, the monoclonal
antibody against lamin B2 (LN43) reacted with a single band
migrating slightly behind the lamin B band at 68 kDa (Figure 1B,
lane 5). The expected mobilities of human lamins A, C, B1 and B2
Table 1 Lamin-specific antibodies used in this study 
Antibody Lamin target Antibody type Dilution used Source 
133A2 Lamin A Mouse/m 1:1000 Hozak et al, 1995 
JoL4 Lamin A Mouse/m Undiluted Dyer et al, 1999 
JoL2 Lamin A/C Mouse/m Undiluted Dyer et al, 1999 
RaLC Lamin C Rabbit/p 1:50 This study 
GaLB1 Lamin B1 Goat/p 1:20 Santa Cruz 
LN43 Lamin B2 Mouse/m 1:100 Dyer et al, 1999 
p = polyclonal antiserum, affinity purified; m = monoclonal antibody.514 RS Venables et al 
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on SDS PAGE are 70 kDa, 65 kDa, 67 kDa and 68 kDa respec-
tively, thus the results of immunoblotting support the specificities
of the antibodies. Since the mobilities of lamin B1 and lamin B2 are
very close, we wished to confirm that the commercial lamin B1
antibody reacted with lamin B1. Therefore, LN43 and the goat
polyclonal antibodies were both used to blot recombinant human
lamin B1. As expected LN43 did not react with recombinant lamin
B1 whereas the goat polyclonal antibody reacted strongly (data not
shown). 
Indirect immunofluorescence was performed on HeLa cells
(Figure 2) and HDF (not shown). JoL2 (Figure 2A), LN43 (Figure
2E), goat anti-lamin B1 (Figure 2D) and rabbit anti-lamin C
(Figure 2C) all gave rise to pronounced ‘rim’ staining in HeLa
cells and proliferating HDF, typical of localisation to the nuclear
lamina. In contrast, JoL4 stained both the nuclear rim and intranu-
clear speckles in both cell types (Figure 2B). Taken together these
data confirm the lamin specificities indicated in Table 1 and espe-
cially that the rabbit polyclonal antibody generated for these
studies specifically reacts with lamin C only. 
Distribution of lamins in normal human skin 
Immunofluorescence on frozen unfixed sections of skin from
different body sites gave consistent results for each lamin. Typical
examples (all from finger skin) are shown in Figure 3. Two
different monoclonal antibodies against lamin A (JoL4 and
133A2) stained dermal fibroblasts and suprabasal epidermal cell
nuclear envelopes intensely, but basal epidermal cells were mostly
unstained (arrows Figure 3 D–E, Figure 4A). In contrast, JoL2
(anti-lamin A/C) stained dermal fibroblasts, suprabasal epidermal
cells and the majority of epidermal basal cells. It was noticeable
that a population of the basal epidermal cells were not stained by
lamin A/C antibodies (Figure 3A–C; Figure 4C). 
The goat anti-lamin B1 antibody stained suprabasal and basal
epidermal cells uniformly. In contrast, dermal fibroblasts were
mostly unstained (arrows, Figure 3G–I). The lamin B2 antibody
LN43 stained all cell types in human skin (Figure 3J–L). The
rabbit polyclonal antibody against lamin C (RaLC) gave rise to a
staining pattern that was almost identical to JoL2 (anti-lamin A/C):
dermal fibroblasts, suprabasal epidermal cells and a majority of
basal epidermal cells were all stained. However, a small number 
of basal epidermal cells were unstained (arrows Figure 3 M–O). 
Taken together, these data indicate differences in the expression
of the lamin sub-types in different cell types within the epidermis.
Lamin B2 is expressed uniformly in all nucleated cells within
human skin (epidermis and dermis). Lamin B1 is expressed
throughout the epidermis but as reported previously (Broers et al,
1997) was not detected in dermal fibroblasts. Lamin A appears to
be expressed in dermal fibroblasts and in suprabasal epidermal
layers, but most cells, in the basal layer did not express lamin A.
Lamin C is also expressed in all dermal fibroblasts and in a
majority of epidermal cells, but lamin C was still not detected in 
a small number of epidermal basal cells. Since JoL2 (A/C) and
RaLC give identical staining patterns (this was confirmed by
double immunofluorescence, not shown), but very different
patterns from those observed with JoL4 and 133A2 (A), we infer
that staining of basal epidermal cells with JoL2 indicates the
presence of lamin C. 
Differences in the expression of lamin A and lamin C in
epidermal basal cells 
In the epidermal basal cell layer, lamin A is not expressed in the
majority of cells, whereas lamin C is absent from approximately 1
in every 40 cells. To investigate this phenomenon further, double
indirect immunofluorescence was performed with monoclonal
antibodies JoL2, JoL4, 133A2 and a rabbit polyclonal antibody
against the proliferation marker Ki67. Whilst again 133A2 and
JoL4 staining (lamin A) was absent from both Ki67-negative and
Ki67-positive cells (Figure 4A, B) in the basal epidermis, JoL2
(A/C) staining was present in and apparently restricted to all Ki67-
positive basal cells (arrowheads Figure 4C, D). These data suggest
that A-type lamins are not expressed in a subpopulation of quies-
cent non-cycling basal cells in the epidermis, but that lamin C, but
not lamin A, is up-regulated in cells that are stimulated to divide.
Lamin A expression appears later in the process of differentiation. 
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Figure 1 Characterization of type specific lamin antibodies by
immunoblotting. (A) GST fusion proteins were used to confirm the specificity
of rabbit anti-lamin C antibody. GST-fusion peptides spanning the following
residues of the lamin C gene, 1–171aa (lanes 1–3), 171–319aa (lanes 4–6)
and 319–572aa (lanes 7–9), were expressed in E. coli and purified. The
purified fragments were resolved on SDS-PAGE, transferred to nitrocellulose
and blotted with the anti-lamin C antibody. The antibody reacted exclusively
with the fusion protein containing the C-terminal fragment 319–572aa that
contains the 6 amino acids specific to lamin C. (B) Nuclear matrix fractions
from Hela cells were resolved on SDS-PAGE, transferred to nitrocellulose
and immunoblotted with one of mAb anti-lamin A/C – JoL2, mAb anti-lamin
A – JoL4, goat anti-lamin B1, mAb anti-lamin B2 – LN43 or rabbit anti-lamin
C. Molecular weight markers = 175, 83, 62, 47.5, 32.5, 25, 16 Lamin expression in basal cell skin carcinomas 515
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Changes in the expression of lamins A and C in basal
cell skin carcinomas 
Changes in the expression of A-type lamins have been reported in
a range of tumours. We investigated lamin expression in a collec-
tion of 16 basal cell skin carcinomas (BCC) taken from a variety
of body sites including back, elbow and neck. In each instance
lamin expression in normal (peri-tumoral) tissue and tumour
lobes was compared. Typical results are displayed in Figures 6
and 7 while a summary of results is displayed in Table 2. All
tumours retained expression of lamin B1, and all except one
expressed lamin B2 also. The A-type lamins were more variable
however. Most tumours expressed either lamin A (detected with
JoL4 and 133A2) or lamin C but not both, although one tumour
had neither. The tumours could therefore be divided up into four
groups on the basis of their lamin expression: A-negative (10/16
tumours), C-negative (5/16 tumours), A/C-negative (1/16
tumours) and A/B2-negative (1/16 tumours). Finally, in one
tumour from the A-negative group, lamin C was expressed but it
was localized in the nucleolus rather than in the nuclear envelope
(Figure 5; Table 2). 
To determine whether lamin expression was correlated with rate
of growth within the tumour, serial sections from the same
tumours were also stained for Ki67 expression. Of the A-negative
tumours, 9 out of 10 were highly proliferative as indicated by
extensive Ki67 staining within the tumour lobe (Table 2). In
Table 2 Expression of individual lamins and Ki67 antigen in basal cell
carcinomas of the skin 
Patient Lamin A Lamin A/C Lamin C Lamin B1 Lamin B2 Ki67 
1. ++ ++ ++ ++ ++ ++ 
2. ++ ++ ++ ++ ++ – 
3. – + + ++ ++ ++ 
4. – + + ++ +++ +++ 
5. – + + ++ ++ +++ 
6. +/– + ++ ++ ++ ++ 
7. – ++ ++ ++ +/– ++ 
8. +/– ++ ++ +++ ++ +++ 
9. +/– ++ ++ ++ +++ +++ 
10. – ++ ++ ++ ++ ++ 
11. – +/– +   ++ ++ +/– 
nucleolar
12. – – – ++ +++ ++ 
13. + + – ++ ++ +/– 
14. + + – ++ ++ +/– 
15. + + – +++ +++ +/– 
16. ++ ++ – +++ ++ – 
Frozen sections of basal cell skin carcinomas were stained individually with
type specific anti-lamin antibodies or with rabbit ant-Ki67. The level of
expression of each antigen within tumour lobes was scored according to an
arbitrary scale in which – indicates low level or absent staining while +++
indicates maximum staining. +/– indicates some positive some negative.
Patient numbers are indicated in the left hand column. Nucleolar (lamin C
patient 96/96) indicates that in this section anti-lamin C antibodies stained
the nucleolus.
Figure 2 Characterization of type specific anti-lamin antibodies by immunofluorescence. HeLa cells were fixed with methanol:acetone and stained with one of
monoclonal antibody anti-lamin A/C JoL2 (A), monoclonal antibody anti-lamin A JoL4 (B), rabbit anti-lamin C (C), goat anti-lamin B1 (D) and mAb anti-lamin B2
LN43 (E). In each sample cells were co-stained with DAPI to reveal the distribution of chromatin. Each micrograph represents a merged image in which the
antibody staining (in red) is superimposed over the DAPI stain (in blue). All lamin antibodies displayed a characteristic nuclear rim staining except JoL 4 that
stained both the nuclear rim and intranuclear foci. Scale bars = 10 mm 
JoL2 JoL4 Lamin C
Lamin B1 LN43
C A B
D E
Ccontrast, 4 out of the 5 C-negative tumours were slow growing as
indicated by an absence of Ki67 staining within the tumour lobe
(Table 2). Therefore as a general rule, absence of lamin A alone
was correlated with rapid growth within the tumour, whereas
absence of lamin C was correlated with slow growth within the
tumour. 
DISCUSSION 
Until now there have been very few attempts to functionally
discriminate between lamins A and C, largely because of the
difficulty in doing so. The generation of an antibody specific to
lamin C now allows a re-examination of the expression of A-type
516 RS Venables et al 
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Figure 3 Lamin expression in normal human finger skin. Frozen sections of normal human finger were stained with either JoL2 (anti-lamin A/C – panels A–C),
133A2 (anti-lamin A – panels D–F), goat anti-lamin B1 (panels G–I), LN43 (anti-lamin B2–panels J–K) or rabbit anti-lamin C (panels M–O). Sections were co-
stained with DAPI to reveal nuclei. Panels A, D, G, J, M show DAPI stained images. Panels B, E, H, K and n show antibody stained images. Panels C, F, I,L and
O show merged images. Arrows illustrate representative nuclei in each section that are unstained. Scale bars = 100 mm Lamin expression in basal cell skin carcinomas 517
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lamins in normal and cancerous tissue. In this investigation, the
absence of expression of one or other A-type lamin in the
majority of a group of 16 basal cell carcinomas of the skin has
been shown (the A-negative BCC type). Most tumours show a
down-regulation of lamin A expression, while a smaller group of
tumours (C-negative) gave negative results for lamin C expres-
sion. In one tumour neither A nor C lamins were detected. In
another tumour, absence of lamin B2 expression accompanied
absence of lamin A expression. In a third BCC, lamin C was
present but abnormally located in the nucleolus. 
Down regulation of A-type lamin expression is a feature of a
number of tumour types including small cell lung carcinomas
(Broers and Ramaekers, 1994), testicular cancer (Machiels et al,
1997) and Hodgkins disease (Jansen et al, 1997). In lung cancer,
changes in the level of lamin expression (Broers et al, 1993) have
been linked to expression of v-rasH (Kaufman et al, 1991), but
there is apparently no common mechanism by which down regu-
lation of lamin expression occurs in tumours. The lamin A gene
has been mapped to 1q12.1-q23, a region of chromosome 1 that is
commonly rearranged in tumours (Kamat et al, 1993). Gene
deletion (Kamat et al, 1993) as well as transcriptional and 
Lamin & DNA Lamin & Ki67
A
A/C
A B
C D
Figure 4 Lamin A and C expression in basal epidermis. Frozen sections of
finger skin were co-stained with JoL2 (anti-lamin A/C), Ki67 and DAPI
(panels A and B) or JoL4 (anti-lamin A), Ki67 and DAPI (panels C and D).
Each panel represents a two colour merged image in which the anti-lamin
antibody stain (in green) is superimposed over the DAPI stain (in blue –
panels A and C) or the Ki67 stain (in red – panels B and D). Arrows indicate
cells that are Ki67 negative: arrowheads indicate cells that are Ki67 positive.
Scale bars = 100 mm 
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Figure 5 Lamin expression in basal cell skin carcinomas. Frozen sections from BCCs were co-stained with one of JoL 4 (anti-lamin A – panels A and B), JoL
2 (anti-lamins A/C – panels C and D), rabbit anti-lamin C (panelsE and F), goat anti-lamin B1 (panels G and H) or LN43 (anti-lamin B2 – panels I and J) and
DAPI. In each panel the antibody stain (in red or green) is superimposed over the DAPI image (in blue). The left hand panels show staining of patient number
46/95 that is a representative lamin A negative, lamin C positive tumour. The right hand panels show an atypical lamin A negative, lamin C positive tumour
(number 96/96) in which lamin C is localized in the nucleolus (arrows panel F). Scale bars = 100 mm 518 RS Venables et al 
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post-transcriptional mechanisms (Lebel et al, 1987; Machiels et
al, 1996) have all been implicated in the loss of lamin A or C
expression. Therefore an important question is whether changes
in lamin expression reflect de-differentiation within the tumour or
is a requisite of tumour progression. 
10 out of the 16 basal cell carcinoma tumour samples included
in this investigation did not show lamin A expression. Lamin A
was not detected in most epidermal basal cells in normal tissue,
suggesting that these cells could be the originators of the A-
negative tumours. Thus the lamin A detected in 6 samples could
reflect up-regulation in these tumours. Finally, 5 samples showed
an absence of lamin C in tumour lobes, although lamin C was
expressed in normal proliferating basal cells of the epidermis,
suggesting that this could reflect downregulation of lamin C
expression. These data therefore suggest a complex pattern of
lamin A/C expression that is not controlled by a single mechanism.
In the majority of cases, absence of lamin A might be explained by
the origin of the tumour (i.e. from lamin-A negative basal
epidermal cells). However previous studies have shown that
expression of lamin A is down-regulated as mouse fibroblasts
progress from a quiescent to a proliferating state (Pugh et al,
1997). The majority of tumours failing to stain with lamin A anti-
bodies were hyperproliferative, as seen by Ki67 staining, and an
alternative explanation for the absence of lamin A in these tumours
is through cell-cycle dependent mechanisms. Tumours displaying
absence of lamin C were generally slower growing (less Ki67).
Changes in lamin C expression resulting from changes in cell
cycle status have not been detected in earlier studies (Dyer et al,
1997; Pugh et al, 1997). Therefore, the absence of lamin C in slow-
growing tumours was somewhat surprising but again indicates
underlying selective changes in lamin expression associated with
the rate of growth in the tumour. Since lamin A and lamin C are
alternatively spliced variants of the same gene (Lin and Worman,
1993), the differences in expression of these two lamins must arise
through post-transcriptional mechanisms (Lanoix et al, 1992). The
availability of specific antibodies against lamin C allows for
further study of this phenomenon which will be essential in order
to understand why the expression of these two lamins is linked to
the rate of tumour growth. 
Lamin A has been reported as an in vitro binding partner for
the tumour suppressor protein p110RB (Ozaki et al, 1994), and
p110RB is tightly associated with nuclear substructures in its
hypophosphorylated form (Templeton et al, 1991; Mancini et al,
1997). Although lamins are normally distributed at the nuclear
envelope, more recent evidence has shown that lamin A is also
located at a number of intranuclear sites (Goldman et al, 1992;
Bridger et al, 1993), which could provide nuclear anchorage sites
for p110RB. If as suggested, nuclear anchorage is important for
the function of p110RB in transcriptional silencing (Mittnacht and
Weinberg, 1991), an absence of lamin A may favour unregulated
cell division. Therefore, its presence or absence may directly
influence the proliferative status of a tumour. That lamin A is
absent in hyperproliferative basal cell skin carcinomas supports
this hypothesis. 
ACKNOWLEDGEMENTS 
This work was generously supported by the Cancer Research Campa-
ign (SP2060/0102 to EBL and SP2101/0401 to CJH, RAQ, EBL) 
Lamin A
Lamin A/C
Lamin C
Lamin B1
Lamin B2
105/95
A
B
C
D
E
Figure 6 Lamin expression in basal cell skin carcinomas. Frozen sections
from BCCs were co-stained with one of JoL4 (anti-lamin A – panel a), JoL2 
(anti-lamin A/C – panel b), rabbit anti-lamin C (panel c), goat anti-lamin B1
(panel d) or LN43 (anti-lamin B2 – panel e) and DAPI. In each panel the
antibody stain (in red or green) is superimposed over the DAPI image (in
blue). The figure illustrates a representative lamin C-negative tumour. Scale
bars = 100 mm 
p = polyclonal antiserum, affinity purified; m = monoclonal antibody. Lamin expression in basal cell skin carcinomas 519
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